C. Robin Ganellin

13.7k total citations · 3 hit papers
197 papers, 10.2k citations indexed

About

C. Robin Ganellin is a scholar working on Molecular Biology, Organic Chemistry and Immunology. According to data from OpenAlex, C. Robin Ganellin has authored 197 papers receiving a total of 10.2k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Molecular Biology, 73 papers in Organic Chemistry and 73 papers in Immunology. Recurrent topics in C. Robin Ganellin's work include Mast cells and histamine (72 papers), Receptor Mechanisms and Signaling (44 papers) and Chemical Synthesis and Analysis (33 papers). C. Robin Ganellin is often cited by papers focused on Mast cells and histamine (72 papers), Receptor Mechanisms and Signaling (44 papers) and Chemical Synthesis and Analysis (33 papers). C. Robin Ganellin collaborates with scholars based in United Kingdom, France and Germany. C. Robin Ganellin's co-authors include W. A. M. Duncan, J. W. Black, E. Marie Parsons, G. J. DURANT, Michael E. Parsons, Walter Schunack, Mike Parsons, Xavier Ligneau, J. C. EMMETT and Holger Stark and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

C. Robin Ganellin

189 papers receiving 9.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition and Antagonism of Histamine H2-receptors

1972 1.8k citations W. A. M. Duncan, C. Robin Ganellin et al. Nature profile →
International Union of Pharmacology. XIII. Classification of Histamine Receptors

1997 758 citations C. Robin Ganellin, Nigel P. Shankley et al. profile →
Metiamide — An orally active histamine H2-receptor antagonist

1973 221 citations W. A. M. Duncan, J. C. EMMETT et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Robin Ganellin United Kingdom	41	5.6k	4.0k	1.8k	1.5k	1.5k	197	10.2k
Holger Stark Germany	51	5.6k 1.0×	4.4k 1.1×	1.5k 0.8×	1.8k 1.2×	1.3k 0.9×	370	10.5k
Rob Leurs Netherlands	71	10.9k 2.0×	8.2k 2.0×	1.8k 1.0×	3.8k 2.5×	2.3k 1.6×	443	19.1k
Walter Schunack Germany	40	4.1k 0.7×	4.0k 1.0×	964 0.5×	756 0.5×	926 0.6×	342	6.7k
Kennan C. Marsh United States	47	4.0k 0.7×	922 0.2×	1.6k 0.9×	774 0.5×	1.4k 0.9×	178	9.7k
Christophe Créminon France	57	3.9k 0.7×	1.1k 0.3×	775 0.4×	1.0k 0.7×	1.7k 1.1×	213	10.0k
Joseph A. Beavo United States	72	16.6k 3.0×	2.2k 0.5×	1.9k 1.0×	2.9k 1.9×	3.8k 2.6×	169	22.2k
Heike Wulff United States	62	9.0k 1.6×	1.5k 0.4×	477 0.3×	3.2k 2.1×	1.9k 1.3×	232	13.3k
Grzegorz Grynkiewicz Poland	28	13.5k 2.4×	1.9k 0.5×	1.2k 0.7×	6.9k 4.5×	3.4k 2.3×	125	22.6k
Alan Saghatelian United States	66	9.2k 1.7×	1.1k 0.3×	877 0.5×	1.2k 0.8×	1.9k 1.3×	158	14.8k
Pier Andrea Borea Italy	64	5.9k 1.1×	778 0.2×	2.4k 1.3×	2.4k 1.6×	942 0.6×	341	13.1k

Countries citing papers authored by C. Robin Ganellin

Since Specialization

Citations

This map shows the geographic impact of C. Robin Ganellin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Robin Ganellin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Robin Ganellin more than expected).

Fields of papers citing papers by C. Robin Ganellin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Robin Ganellin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Robin Ganellin. The network helps show where C. Robin Ganellin may publish in the future.

Co-authorship network of co-authors of C. Robin Ganellin

This figure shows the co-authorship network connecting the top 25 collaborators of C. Robin Ganellin. A scholar is included among the top collaborators of C. Robin Ganellin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Robin Ganellin. C. Robin Ganellin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ganellin, C. Robin, Roy Jefferis, & Stanley M. Roberts. (2013). Introduction to biological and small molecule drug research and development : theory and case studies. Elsevier eBooks. 13 indexed citations

Ligneau, Xavier, Heinz H. Pertz, Jean‐Michel Arrang, et al.. (2004). Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry. 12(10). 2727–2736. 15 indexed citations

Dougalis, Antonios, George Lees, & C. Robin Ganellin. (2003). The sleep inducing brain lipid cis-oleamide (cOA) does not modulate serotonergic transmission in the CA1 pyramidal neurons of the hippocampus in vitro. Neuropharmacology. 46(1). 63–73. 6 indexed citations

Erhardt, Paul, John G. Topliss, Per Lindberg, et al.. (2001). La Química Farmaceútica en el desarrollo de los pueblos, biodiversidad y productos naturales. 26–31.

Ganellin, C. Robin. (2001). Two routes to becoming a medicinal chemist. UCL Discovery (University College London). 1 indexed citations

Weissig, Volkmar, et al.. (2001). DNA binding cationic bolasomes with delocalized charge center - A structure-activity relationship study. UCL Discovery (University College London). 7 indexed citations

Stark, Holger, Bassem Sadek, Michael Krause, et al.. (2000). Novel Histamine H₃-Receptor Antagonists with Carbonyl-Substituted 4-(3-(Phenoxy)propyl)-1H-imidazole Structures like Ciproxifan and Related Compounds. Journal of Medicinal Chemistry. 43(21). 3987–3994. 39 indexed citations

Ganellin, C. Robin. (2000). University education of medicinal chemists: comparison of eight countries. European Journal of Medicinal Chemistry. 35(1). 163–174. 5 indexed citations

Morisset‐Lopez, Séverine, A. Rouleau, Xavier Ligneau, et al.. (2000). High constitutive activity of native H3 receptors regulates histamine neurons in brain. Nature. 408(6814). 860–864. 392 indexed citations

10.

Galanakis, Dimitrios, et al.. (1999). Abstract: UCL1848: a novel bis-quinolinium cyclophane, which blocks apamin-sensitive K+ channels with nanomolar affinity. British Journal of Pharmacology. 8 indexed citations

11.

Demphel, Stéphane, Chantal Fuseau, Michel Bottlaender, et al.. (1998). Radiosynthesis and biodistribution of two potential antagonists of cerebral histamine H3 receptors for PET studies: [18F]FUB 272 and [11C]UCL 1829. UCL Discovery (University College London). 2 indexed citations

12.

Ganellin, C. Robin, et al.. (1998). Medicinal chemistry graduate school curriculum and contribution to pharmaceutical industry in Japan. UCL Discovery (University College London). 1 indexed citations

13.

Ganellin, C. Robin & D. J. Triggle. (1997). Dictionary of Pharmacological Agents. UCL Discovery (University College London). 22 indexed citations

14.

Ganellin, C. Robin, et al.. (1990). Chemical data, structures and bibliographies. 2 indexed citations

15.

Ganellin, C. Robin, R R Griffiths, B. K. Leigh, et al.. (1988). Zolantidine (SK&F 95282) is a potent selective brain‐penetrating histamine H₂‐receptor antagonist. British Journal of Pharmacology. 93(1). 69–78. 57 indexed citations

16.

Shankley, Nigel P., et al.. (1988). Correlation between log P_OCT/H2O and pK_B estimates for a series of muscarinic and histamine H₂‐receptor antagonists. British Journal of Pharmacology. 94(1). 264–274. 28 indexed citations

17.

DURANT, G. J., et al.. (1977). ChemInform Abstract: CYANOGUANIDINE‐THIOUREA EQUIVALENCE IN THE DEVELOPMENT OF THE HISTAMINE H2‐RECEPTOR ANTAGONIST, CIMETIDINE. Chemischer Informationsdienst. 8(43). 1 indexed citations

18.

Ganellin, C. Robin, G. J. DURANT, & J. C. EMMETT. (1976). Some chemical aspects of histamine H2-receptor antagonists.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 35(8). 1924–30. 29 indexed citations

19.

Brimblecombe, R.W., W. A. M. Duncan, G. J. DURANT, et al.. (1975). Proceedings: The pharmacology of cimetidine, a new histamine H2-receptor antagonist.. British Journal of Pharmacology. 53(3). 435. 34 indexed citations

20.

Ganellin, C. Robin & R. G. W. Spickett. (1965). Compounds Affecting the Central Nervous System. I. 4-Piperidones and Related Compounds. Journal of Medicinal Chemistry. 8(5). 619–625. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact